TREA

97812982 - S SEQUEL

Follow

Information

  • Trademark
  • 97812982
  • Serial Number
    97812982
  • Filing Date
    February 27, 2023
    2 years ago
  • Transaction Date
    April 03, 2025
    10 months ago
  • Status Date
    March 04, 2025
    11 months ago
  • Published for Opposition Date
    February 27, 2024
    a year ago
  • Location Date
    March 04, 2025
    11 months ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    STIGLITZ, SUSAN
  • Attorney Docket Number
    TM008
    Attorney Name
    MARK E TETREAULT
    Law Office Assigned Location Code
    L90
  • Owners
Information
Mark Drawing Code
3
Mark Identification
S SEQUEL
Case File Statements
  • GS0411: Educational services, namely, creating and developing web-based and in person classes, seminars, workshops and programs in the field of managing and living with chronic disease; personalized training and coaching in the use of monitoring devices and infusion pumps in the treatment of chronic disease; training of healthcare providers in chronic disease treatment and the use of infusion pumps and infusion sets
  • DM0000: The mark consists of a stylized "S" formed from two interlocked semicircles followed by the word SEQUEL.
  • GS0091: Software as a Medical Device (SaMD), downloadable, for predicting blood analyte levels and adjusting infusion pump settings based on personalized data for use in connection with a device for the delivery of therapeutic agents for the treatment of disease; Downloadable educational mobile applications featuring information and instruction on managing, treating and living with chronic disease; batteries; battery chargers
  • GS0051: Infusion cartridges sold pre-filled with medication for medical use in the field of cardiovascular disease, diabetes, asthma, kidney disease, and cancer; Adhesive overlays in the nature of adhesive medical tape and adhesive bandages for use with infusion pumps and associated devices, all of the foregoing for use in connection with a device for the delivery of therapeutic agents for the treatment of disease
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0351: Providing a trade-in program for drug delivery and chronic disease management devices; Pharmaceutical services, namely, mail order pharmacy services and processing online and telephone prescription orders in retail and central fill pharmacies featuring chronic disease management supplies, medications, drugs and other prescriptions
  • GS0441: Interactive medical monitoring and alert services for reminding infusion pump users of medical dosage for medical treatment purposes in the nature of monitoring and managing chronic disease; Providing medical information to infusion pump users for use in connection with a device for the delivery of therapeutic agents for the treatment of disease in the form of reports in the field of chronic disease management; Providing a website featuring general medical information related to chronic diseases, including advice on treatment options and chronic disease management; providing online searchable medical databases in the field of chronic disease management for patients, their families and caregivers, and healthcare practitioners; medical consultation services, namely, patient ambassador program to communicate medical information to people with chronic disease, all of the foregoing related to use of a device for the delivery of therapeutic agents for the treatment of disease
  • GS0101: Medical devices, namely, infusion and injection devices for administering therapeutic agents for the treatment of disease, and pouches and mounts used therewith; medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time for the treatment of disease; medical apparatus for monitoring blood analyte levels for use in connection with a device for the delivery of therapeutic agents for the treatment of disease; implantable subcutaneous devices for the delivery of therapeutic agents for the treatment of disease, sold empty, in the nature of medical fluid injectors; on-body medical fluid injectors for the delivery of therapeutic agents for the treatment of disease; chronic disease management devices in the nature of medical sensors for use in connection with a device for the delivery of therapeutic agents for the treatment of disease that are implanted or inserted into the human body used to continuously gather human biometric data for monitoring the concentration of analytes in the human body and also including accessories therefor, namely, receivers, sensor housings and sensor insertion devices sold as a unit; medical infusion sets comprised of infusion tubing, infusion needles, needle guards, connectors, attachment clips, and accessories therefor, all used for the delivery of therapeutic agents for the treatment of disease
  • GS0421: Software-as-a-service (SAAS) featuring software for use in the acquisition, capture, processing, presentation, transmission and storage of medical and physiological data obtained from medical sensors that are implanted or inserted into the human body; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to managing chronic disease, medication and analyte levels; Upgrading of computer software, namely, Software as a Medical Device (SaMD) for predicting blood analyte levels and adjusting infusion pump settings based on personalized data for use in connection with a device for the delivery of therapeutic agents for the treatment of disease
Case File Event Statements
  • 3/17/2023 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 3/2/2023 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 3/16/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/28/2023 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/29/2023 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/29/2023 - 2 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/29/2023 - 2 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/30/2023 - 2 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/30/2023 - 2 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/30/2023 - 2 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/5/2023 - 2 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/19/2023 - 2 years ago
    12 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 1/24/2024 - 2 years ago
    13 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 1/24/2024 - 2 years ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/24/2024 - 2 years ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/24/2024 - 2 years ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/24/2024 - 2 years ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/24/2024 - 2 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/7/2024 - 2 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/7/2024 - 2 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/27/2024 - a year ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/4/2024 - a year ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/26/2024 - a year ago
    25 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 3/22/2024 - a year ago
    23 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 8/26/2024 - a year ago
    24 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 1/22/2025 - a year ago
    26 - OPPOSITION DISMISSED NO. 999999 Type: OP.D
  • 1/22/2025 - a year ago
    28 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN
  • 1/22/2025 - a year ago
    27 - OPPOSITION TERMINATED NO. 999999 Type: OP.T
  • 3/4/2025 - 11 months ago
    29 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM